Back to Search
CHARLES MARRIOTT, MD
MD
Surgery Physician
NPI: 1871122135IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
V6355(TX)DR.0075462(CO)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
CMS Specialties
PrimaryGENERAL SURGERY
Education
GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
Class of 2020
Research & Publications (20)
Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
PMID 16942848·Int J Pharm·2006
8-other
Dry powder formulations for inhalation of fluticasone propionate and salmeterol xinafoate microcrystals.
PMID 18506819·J Pharm Sci·2009
8-other
Cluster of sylvatic epidemic typhus cases associated with flying squirrels, 2004-2006.
PMID 19624912·Emerg Infect Dis·2009
5-case
Multilayer PVA adsorption onto hydrophobic drug substrates to engineer drug-rich microparticles.
PMID 18023332·Eur J Pharm Sci·2008
8-other
Investigations into the formulation of metered dose inhalers of salmeterol xinafoate and fluticasone propionate microcrystals.
PMID 18509598·Pharm Res·2008
8-other
Polymorphic control of inhalation microparticles prepared by crystallization.
PMID 18582548·Int J Pharm·2008
4-observational
Inability to process and store proinsulin in transdifferentiated pancreatic acinar cells lacking the regulated secretory pathway.
PMID 18180315·J Endocrinol·2008
7-preclinical
6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications.
PMID 18344441·J Nucl Med·2008
6-review
Developing an environmentally benign process for the production of microparticles: amphiphilic crystallization.
PMID 18082385·Eur J Pharm Biopharm·2008
8-other
A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors.
PMID 18381947·Clin Cancer Res·2008
3-trial
Comparison of salmeterol xinafoate microparticle production by conventional and novel antisolvent crystallization.
PMID 17981448·Eur J Pharm Biopharm·2008
4-observational
Selenium stimulates pancreatic beta-cell gene expression and enhances islet function.
PMID 18538137·FEBS Lett·2008
7-preclinical
Back to basics: the development of a simple, homogenous, two-component dry-powder inhaler formulation for the delivery of budesonide using miscible vinyl polymers.
PMID 17680663·J Pharm Sci·2008
8-other
Radiation exposure for 'caregivers' during high-dose outpatient radioiodine therapy.
PMID 16825250·Radiat Prot Dosimetry·2007
8-other
Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
PMID 17064863·Int J Pharm·2007
8-other
Influence of realistic inspiratory flow profiles on fine particle fractions of dry powder aerosol formulations.
PMID 17177114·Pharm Res·2007
3-trial
Optimizing aerosol gene delivery and expression in the ovine lung.
PMID 17235313·Mol Ther·2007
7-preclinical
The correlation of urinary levels of albuterol and its metabolites isomers following inhalation from a dry powder inhaler and in vitro particle size characterisation.
PMID 16325440·Pulm Pharmacol Ther·2007
2-rct
Characterisation of a carrier-free dry powder aerosol formulation using inertial impaction and laser diffraction.
PMID 16900410·Pharm Res·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1800 15TH ST STE 200
GREELEY, CO 80631 - Phone
- (970) 810-8216
Quick Facts
- NPI
- 1871122135
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile